Apyx Medical Corp Income Statement
APYX|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Apyx Medical Corp reported $53M in revenue and $11M in net loss for FY2025. Revenue has grown at a 4.9% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.02 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $52.8M | $48.1M | $44.5M | $44.5M | $27.7M | $28.2M | $10.2M | $8.8M | $29.5M | $27.7M | $23.7M | $6.5M | $25.4M | $24.2M | $27.0M |
| Cost of Revenue | $19.8M | $18.7M | $15.4M | $15.4M | $10.2M | $9.1M | $3.3M | $3.7M | $17.0M | $18.7M | $14.5M | $16.3M | $14.7M | $14.2M | $15.1M |
| Gross Profit | $33.0M | $29.4M | $29.1M | $29.1M | $17.5M | $19.1M | $7.0M | $5.1M | $12.6M | $9.0M | $9.2M | $11.3M | $10.7M | $10.0M | $11.9M |
| SG&A Expense | $15.8M | $18.9M | $20.5M | $20.5M | $11.7M | $13.7M | $8.7M | $6.2M | $8.4M | $6.7M | $5.8M | $4.3M | $4.3M | $4.9M | $4.7M |
| R&D Expense | $3.4M | $5.1M | $4.5M | $4.5M | $3.9M | $3.7M | $1.9M | $1.0M | $2.2M | $1.4M | $1.3M | $1.3M | $1.2M | $1.9M | $2.1M |
| Operating Income | -$6.4M | -$18.8M | -$23.6M | -$23.6M | -$20.1M | -$20.9M | -$13.9M | -$11.4M | -$7.0M | -$5.8M | -$3.7M | $1.0M | -$18.0K | -$2.8M | $715.0K |
| Interest Expense | - | - | $15.0K | $15.0K | $46.0K | $8.0K | $136.0K | $158.0K | -$158.0K | -$151.0K | -$237.0K | -$232.0K | -$237.0K | -$223.0K | -$52.0K |
| Income Tax | $270.0K | $252.0K | $367.0K | $367.0K | -$7.5M | -$130.0K | -$156.0K | $64.0K | $25.0K | $4.0M | -$1.6M | $217.0K | $77.0K | -$927.0K | $67.0K |
| Net Income | -$11.2M | -$23.5M | -$23.2M | -$23.2M | -$11.9M | -$19.7M | -$5.1M | -$11.6M | -$5.4M | -$17.3M | -$4.3M | $617.0K | $109.0K | -$1.5M | $596.0K |
| EPS (Basic) | -$0.66 | -$0.54 | -$0.67 | -$0.44 | -$0.35 | - | -$0.16 | -$0.14 | $0.34 | -$1.03 | -$0.40 | $0.04 | $0.01 | -$0.09 | $0.04 |
| EPS (Diluted) | - | - | -$0.67 | -$0.44 | -$0.35 | -$0.58 | -$0.17 | -$0.15 | $0.24 | -$1.03 | -$0.40 | $0.03 | $0.01 | -$0.09 | $0.03 |
| Shares Outstanding | 37.8M | 34.6M | 34.6M | 34.4M | 34.3M | 34.2M | 33.6M | 32.9M | 30.9M | 27.1M | 17.9M | 17.7M | 17.6M | 17.6M | 17.6B |
| Gross Margin | 62.5% | 61.0% | 65.5% | 65.5% | 63.2% | 67.6% | 68.0% | 58.0% | 42.5% | 32.5% | 38.9% | 174.8% | 42.2% | 41.2% | 44.0% |
| Operating Margin | -12.2% | -39.2% | -52.9% | -52.9% | -72.5% | -73.9% | -135.7% | -129.2% | -23.7% | -21.1% | -15.5% | 16.1% | -0.1% | -11.4% | 2.6% |
| Profit Margin | -21.2% | -48.8% | -52.1% | -52.1% | -42.9% | -69.8% | -49.5% | -131.0% | -18.2% | -62.4% | -18.3% | 9.5% | 0.4% | -6.3% | 2.2% |